VOLVER
Academy
Academy
Programa
Adapte el horario de la clase / congreso transmitido en vivo a su zona horaria
Referencia de zona horaria: (UTC-04:00) America, New York
LIVE ONLINE SUMMIT INJECTABLES
Focus on periorbital trends
Sala: Webinar
Fecha: sábado 29 enero 2022 de 07:00 a 11:00
Formato: SESIÓN ENFOCADA > presentación que cubre una temática principal del congreso
Fecha: sábado 29 enero 2022 de 07:00 a 11:00
Formato: SESIÓN ENFOCADA > presentación que cubre una temática principal del congreso
Las presentaciones
| Horas | Oradores | Título de la presentación | Resumen | Número |
| 07:00 | Introduction and what's hot at IMCAS | 115161 | ||
| 07:10 | Part 1 - Anatomy for periorbital area injections | 115152 | ||
| 07:10 | Orbital dissection | 115153 | ||
| 07:25 | Live HA & toxin simulator injection (with the support of Laboratoires Vivacy) | 115154 | ||
| 07:40 | Live periorbital injection on a patient (with the support of Galderma) | 115157 | ||
| 07:55 | Live ultrasonography mapping | 115158 | ||
| 08:05 | Ultrasound imaging: how this will change cosmetic medicine | 115206 | ||
| 08:20 | Tear through – Facial vein and filler treatments | 115207 | ||
| 08:30 | Controversial anatomy - Upper face muscles | 115155 | ||
| 08:45 | Live Q&A with the audience | 115156 | ||
| 09:00 | Part 2 - Galderma symposium - ALLUZIENCE the new liquid BoNT-A neuromodulator | 115210 | ||
| 09:00 | Welcome and opening | 115211 | ||
| 09:05 | The innovation behind Alluzience | 115212 | ||
| 09:20 | The science behind Alluzience | 115163 | ||
| 09:35 | Alluzience in clinical practice | 115213 | ||
| 09:50 | Panel discussion and Q&A | 115234 | ||
| 09:55 | Closing | 115235 | ||
| 10:00 | Part 3 - Toxins product analysis and new launches | 115164 | ||
| 10:00 | Moderator | 115165 | ||
| 10:00 | Moderator | 115208 | ||
| 10:00 | Moderator | 115166 | ||
| 10:00 | Moderator | 115167 | ||
| 10:00 | Panel discussion with Allergan | 115169 | ||
| 10:00 | Panel discussion with CNBG | 115170 | ||
| 10:00 | Panel discussion with Evolus | 115171 | ||
| 10:00 | Panel discussion with Galderma | 115172 | ||
| 10:00 | Panel discussion with Hugel | 115173 | ||
| 10:55 | Conclusion | 115174 | ||
